Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Peanut oral immunotherapy during omalizumab protection; a clinical trial on severely peanut allergic adolescents
Show others and affiliations
2017 (English)In: Allergy. European Journal of Allergy and Clinical Immunology, ISSN 0105-4538, E-ISSN 1398-9995, Vol. 72, p. 65-66Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
WILEY , 2017. Vol. 72, p. 65-66
National Category
Immunology in the medical area
Identifiers
URN: urn:nbn:se:kth:diva-214896ISI: 000408773100105OAI: oai:DiVA.org:kth-214896DiVA, id: diva2:1151257
Conference
Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, JUN 17-21, 2017, Helsinki, FINLAND
Note

QC 20171023

Available from: 2017-10-23 Created: 2017-10-23 Last updated: 2018-01-13Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

http://www.eaaci.org/

Search in DiVA

By author/editor
Kalm, Frida
By organisation
Proteomics and Nanobiotechnology
In the same journal
Allergy. European Journal of Allergy and Clinical Immunology
Immunology in the medical area

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 57 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf